Get notified when PMN files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Going Concern (new) — The auditor's report includes a going-concern explanatory paragraph, and the company lists liquidity risk as a going concern, indicating substantial doubt about its ability to continue operations.
ProMIS Neurosciences launches at-the-market offering at $1.28/share; implied market cap $25M
Filed March 31, 2025 · ~1 min read
Key Changes
-
high
ProMIS Neurosciences is selling up to 10,354,794 primary shares at $1.28 per share, for gross proceeds of an undisclosed amount.
The Offering verify on EDGAR → -
medium
The offering is at-the-market, with no minimum amount; actual proceeds may be lower and are not determinable.
Use of Proceeds verify on EDGAR → -
medium
Net proceeds are intended for R&D, working capital, and general corporate purposes, with no specific allocation.
Use of Proceeds verify on EDGAR →
3 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (MRSH 10-Q) is open in full — no account needed.
Partner
Trade PMN commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 2, 2026 · How we verify